Table 2. The comparison of the genotypes and alleles of eight study polymorphisms between HCC patients and controls.

Polymorphisms	Class	WW	WM	MM	*P	M	P
rs199514452		AA	AT	TT		T
c.31T > A	Patients	170	78	9	0.847	18.66%	0.837
	Controls	175	82	7		18.18%
rs201540428		TT	TA	AA		A
c.34A > T	Patients	163	84	10	0.754	20.23%	0.447
	Controls	159	93	12		22.16%
rs201614260		CC	CG	GG		G
c.84G > C	Patients	218	39	0	0.043	7.59%	0.039
	Controls	240	24	0		4.55%
rs17879702		CC	CT	TT		T
c.133C > T	Patients	201	52	4	0.021	11.67%	0.007
	Controls	230	32	2		6.82%
rs17880292		GG	GA	AA		A
c.256G > A	Patients	215	42	0	0.177	8.17%	0.673
	Controls	221	39	4		8.90%
rs17879599		GG	GC	CC		C
c.299G > C	Patients	129	113	15	< 0.001	27.82%	< 0.001
	Controls	177	76	11		18.56%
rs17424145		TT	TC	CC		C
c.341T > C	Patients	227	30	0	0.311	5.84%	0.277
	Controls	241	23	0		4.36%
rs35445101		AA	AG	GG		G
c.790T > C	Patients	213	43	1	0.247	8.75%	0.193
	Controls	210	49	5		11.17%

Abbreviations: WW, homozygous wild genotype; WM, heterozygous genotype; MM, homozygous mutant genotype; M, mutant allele. P was calculated by the *Fisher's exact test for genotype comparisons and by the χ²-test for allele comparisons between patients and controls.